TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · Real-Time Price · USD
0.624
-0.006 (-0.94%)
At close: Nov 22, 2024, 4:00 PM
0.605
-0.019 (-3.03%)
After-hours: Nov 22, 2024, 7:53 PM EST
TC Biopharm (Holdings) Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.98 | 2.46 | 4.81 | 1.57 | 0.75 | 0.96 |
Cash & Short-Term Investments | 0.98 | 2.46 | 4.81 | 1.57 | 0.75 | 0.96 |
Cash Growth | -79.60% | -48.78% | 206.89% | 109.45% | -21.80% | - |
Accounts Receivable | - | - | - | - | - | 0.11 |
Other Receivables | 1.21 | 1.1 | 1.78 | 1.41 | 1.18 | 2.91 |
Receivables | 1.21 | 1.1 | 1.78 | 1.41 | 1.18 | 3.02 |
Prepaid Expenses | 0.77 | 0.83 | 0.84 | 0.81 | 0.23 | 0.24 |
Other Current Assets | 1.24 | 1.31 | 0.03 | 0.07 | 0.05 | 0 |
Total Current Assets | 4.2 | 5.7 | 7.45 | 3.86 | 2.22 | 4.22 |
Property, Plant & Equipment | 2.45 | 2.62 | 3.29 | 3.68 | 4.63 | 5.61 |
Other Intangible Assets | 0.61 | 0.62 | 0.55 | 0.48 | 0.42 | 0.31 |
Accounts Payable | 1.93 | 1.85 | 0.88 | 1.42 | 0.64 | 0.63 |
Accrued Expenses | 2.19 | 2.41 | 0.94 | 2.33 | 0.92 | 0.48 |
Short-Term Debt | - | - | 0.65 | 13.73 | - | - |
Current Portion of Leases | 0.31 | 0.31 | 0.33 | 0.77 | 0.44 | 0.41 |
Current Income Taxes Payable | 0.29 | 0.14 | 0.29 | 0.31 | 0.14 | 0.27 |
Current Unearned Revenue | - | - | - | 1.98 | 1.98 | 2.03 |
Other Current Liabilities | 0.05 | 0.05 | 6.06 | 0.04 | 0.06 | 0.06 |
Total Current Liabilities | 4.76 | 4.75 | 9.16 | 20.58 | 4.19 | 3.88 |
Long-Term Leases | 1.42 | 1.5 | 1.8 | 2.14 | 2.58 | 3.02 |
Long-Term Unearned Revenue | - | - | - | 1.87 | 3.84 | 5.77 |
Common Stock | 0.4 | 0.4 | 0.4 | 0.2 | 0.19 | 1.78 |
Additional Paid-In Capital | 42.84 | 41.12 | 33.31 | - | - | 11.1 |
Retained Earnings | -42.16 | -38.84 | -33.37 | -33.47 | -19.89 | -15.42 |
Comprehensive Income & Other | - | - | - | 16.71 | 16.35 | - |
Total Liabilities & Equity | 7.26 | 8.93 | 11.29 | 8.02 | 7.27 | 10.14 |
Total Debt | 1.73 | 1.8 | 2.78 | 16.63 | 3.03 | 3.44 |
Net Cash (Debt) | -0.75 | 0.66 | 2.03 | -15.07 | -2.28 | -2.48 |
Net Cash Growth | - | -67.41% | - | - | - | - |
Net Cash Per Share | -11.32 | 21.41 | - | - | - | - |
Filing Date Shares Outstanding | 0.49 | 0.32 | 0.01 | 0.01 | 0.01 | - |
Total Common Shares Outstanding | 0.32 | 0.1 | - | 0.01 | 0.01 | - |
Working Capital | -0.56 | 0.95 | -1.72 | -16.72 | -1.97 | 0.34 |
Book Value Per Share | 3.38 | 26.11 | - | -1583.99 | -334.51 | - |
Tangible Book Value | 0.47 | 2.07 | -0.22 | -17.04 | -3.77 | -2.85 |
Tangible Book Value Per Share | 1.48 | 20.13 | - | -1630.25 | -376.86 | - |
Machinery | 0.45 | 0.45 | 0.43 | 0.42 | 0.41 | 0.4 |
Source: S&P Capital IQ. Standard template.
Financial Sources.